China's WuXi PharmaTech Closes Initial Public Offering (China)
This article was originally published in PharmAsia News
Executive Summary
China-based WuXi PharmaTech Inc. announced the closure of its first public offering on the New York Stock Exchange on August 15. WuXi PharmaTech is an outsourcing company which concentrates on biotechnology research and development. It had been trading since August 9 under the symbol "WX." (Click here for more - May Require Free Registration